June 25, 2024

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, DC 20549

 

Re:

NovaBay Pharmaceuticals, Inc. (the “Company”)

Form S-1, File No. 333-280363

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 under the Securities Act of 1933, as amended, the Company hereby requests that the Securities and Exchange Commission take appropriate action to cause the above-referenced Registration Statement on Form S-1 to become effective as of 5:00 p.m. (Eastern time) on Thursday, June 27, 2024, or as soon as practicable thereafter.

 

 

 

Very truly yours,
     
 

NovaBay Pharmaceuticals, Inc.
     
 

By:

/s/ Justin Hall
   

Justin Hall
   

Chief Executive Officer and General Counsel

 

 

cc:         Abby E. Brown, Squire Patton Boggs (US) LLP